Porter Derrell

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Porter Derrell's trades of Acumen Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
55.94
Quantity 67,582 +9.0%
Value US$279,699
Transaction date
Proposed sale
Price
205.27
Quantity 29,760
Value US$2,461,263
Transaction date
Proposed sale
Price
2.33
Quantity 12,800
Value US$29,768
Transaction date
Sale
Price
2.35
Quantity 6,460 -11.8%
Value US$15,149
Transaction date
Proposed sale
Price
2.35
Quantity 6,460
Value US$15,149
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-17
S Sale
67,582 +9.0%
55.94
US$279,699 		67,582 +9.0% 55.94 US$279,699
2026-06-17 2026-06-17
PrS Proposed sale
29,760
205.27
US$2,461,263 		29,760 205.27 US$2,461,263
2026-06-17 2026-06-16
S Sale
45,821 +5.7%
217.76
US$1,537,833 		45,821 +5.7% 217.76 US$1,537,833
2026-06-16 2026-06-16
PrS Proposed sale
12,800
2.33
US$29,768 		12,800 2.33 US$29,768
2026-06-17 2026-06-15
S Sale
6,460 -11.8%
2.35
US$15,149 		6,460 -11.8% 2.35 US$15,149
2026-06-15 2026-06-15
PrS Proposed sale
6,460
2.35
US$15,149 		6,460 2.35 US$15,149
2019-02-19 2019-02-15
PlS Planned sale
5,909 -21.4%
40.00
US$236,360 		5,909 -21.4% 40.00 US$236,360